Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2016

Open Access 01-12-2016 | Research article

Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional survey

Authors: Nancy L. Hancock, Carla J. Chibwesha, Samuel Bosomprah, Jonathan Newman, Mwangelwa Mubiana-Mbewe, Elizabeth Siyama Sitali, Carolyn Bolton-Moore, Clara Mbwili-Muleya, Benjamin H. Chi

Published in: BMC Public Health | Issue 1/2016

Login to get access

Abstract

Background

Family planning (FP) is an essential health service and an important part of comprehensive HIV care. However, there is limited information about the contraceptive needs of people living with HIV in sub-Saharan Africa, which in turn has hampered efforts to expand and integrate FP services into existing HIV programs.

Methods

We performed a cross-sectional survey to determine FP prevalence and predictors among HIV-positive women and men attending 18 public antiretroviral therapy (ART) clinics in Lusaka, Zambia. Trained peer counselors administered the 10-question survey to those seeking care for five days at each of the target sites.

Results

From February to April 2014, we surveyed 7,046 HIV-infected patients receiving routine HIV services. Use of modern contraception was reported by 69 % of female ART patients and 79 % of male ART patients. However, highly effective contraceptive use and dual method use were low among women (38 and 25 %, respectively) and men (19 and 14 %, respectively). HIV disclosure status (adjusted odds ratio (AOR) = 4.91, 95 % confidence interval (CI) = 3.32–7.24 for women, AOR = 3.58, 95 % CI = 2.39–5.38 for men) and sexual activity in the last 6 months (AOR = 5.80, 95 % CI = 4.51–7.47 for women, AOR = 6.24, 95 % CI = 3.51–11.08 for men) were associated with modern contraceptive use in multivariable regression. Most respondents said they would access FP services if made available within ART clinic.

Conclusions

While FP-ART integration may be a promising strategy for increasing FP service uptake, such services must focus on assessing sexual activity and advocating for dual method use to increase effective contraceptive use and prevent unintended pregnancies.
Literature
1.
Darroch JE, Sedgh G, Ball H. Contraceptive technologies: Responding to women’s needs. In. New York: Guttmacher Institute; 2011.
2.
Singh S, Sedgh G, Hussain R. Unintended Pregnancy: Worldwide Levels, Trends, and Outcomes. Stud Fam Plann. 2010;41(4):241–50.CrossRefPubMed
3.
The Inter-agency Task Team (IATT) for Prevention and Treatment of HIV in Pregnant Women, Mothers, and their Children. Preventing HIV and unintended pregnancies: Strategic framework 2010–2015. In: The Inter-agency Task Team (IATT) Reports. Washington: UNFPA; 2012.
4.
Homsy J, Bunnell R, Moore D, King R, Malamba S, Nakityo R, Glidden D, Tappero J, Mermin J. Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS One. 2009;4(1):e4149.CrossRefPubMedPubMedCentral
5.
Myer L, Carter RJ, Katyal M, Toro P, El-Sadr WM, Abrams EJ. Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS Med. 2010;7(2):e1000229.CrossRefPubMedPubMedCentral
6.
Tweya H, Feldacker C, Breeze E, Jahn A, Haddad LB, Ben-Smith A, Chaweza T, Phiri S. Incidence of pregnancy among women accessing antiretroviral therapy in urban Malawi: a retrospective cohort study. AIDS Behav. 2013;17(2):471–8.CrossRefPubMed
7.
Beyeza-Kashesya J, Ekstrom AM, Kaharuza F, Mirembe F, Neema S, Kulane A. My partner wants a child: a cross-sectional study of the determinants of the desire for children among mutually disclosed sero-discordant couples receiving care in Uganda. BMC Public Health. 2010;10:247.CrossRefPubMedPubMedCentral
8.
Cooper D, Harries J, Myer L, Orner P, Bracken H, Zweigenthal V. “Life is still going on”: reproductive intentions among HIV-positive women and men in South Africa. Soc Sci Med. 2007;65(2):274–83.CrossRefPubMed
9.
10.
Rollins NC, Coovadia HM, Bland RM, Coutsoudis A, Bennish ML, Patel D, Newell ML. Pregnancy outcomes in HIV-infected and uninfected women in rural and urban South Africa. J Acquir Immune Defic Syndr. 2007;44(3):321–8.CrossRefPubMed
11.
The Inter-agency Task Team (IATT) for Prevention and Treatment of HIV in Pregnant Women, Mothers, and their Children. Preventing HIV and unintended pregnancies: Strategic framework 2010–2015. Washington: The Inter-agency Task Team (IATT); 2012.
12.
Zaba B, Calvert C, Marston M, Isingo R, Nakiyingi-Miiro J, Lutalo T, Crampin A, Robertson L, Herbst K, Newell M-L et al. Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA). Lancet. 2013;381(9879):1763–71.CrossRefPubMedPubMedCentral
13.
Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, Gonzalez-Medina D, Barber R, Huynh C, Dicker D et al. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):980–1004.CrossRefPubMedPubMedCentral
14.
Coutsoudis A, England K, Rollins N, Coovadia H, Newell ML, Bland R. Women’s morbidity and mortality in the first 2 years after delivery according to HIV status. AIDS. 2010;24(18):2859–66.CrossRefPubMed
15.
Landes M, van Lettow M, Bedell R, Mayuni I, Chan AK, Tenthani L, Schouten E. Mortality and health outcomes in HIV-infected and HIV-uninfected mothers at 18–20 months postpartum in Zomba District, Malawi. PLoS One. 2012;7(9):e44396.CrossRefPubMedPubMedCentral
16.
Matthews LT, Kaida A, Kanters S, Byakwagamd H, Mocello AR, Muzoora C, Kembabazi A, Haberer JE, Martin JN, Bangsberg DR et al. HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods. AIDS. 2013;27 Suppl 1:S105–12.CrossRefPubMedPubMedCentral
17.
Ki-Moon B. Global strategy for women’s and children’s health. New York: The Partnership for Maternal, Newborn and Child Health; 2010.
18.
Doherty K, Ciaranello A. What is needed to eliminate new pediatric HIV infections: the contribution of model-based analyses. Curr Opin HIV AIDS. 2013;8(5):457–66.CrossRefPubMedPubMedCentral
19.
Mahy M, Stover J, Kiragu K, Hayashi C, Akwara P, Luo C, Stanecki K, Ekpini R, Shaffer N. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect. 2010;86 Suppl 2:ii48–55.PubMedPubMedCentral
20.
President’s Emergency Plan for AIDS Relief. PEPFAR blueprint: Creating an AIDS-free generation. Washington: United States State Department; 2012.
21.
22.
Wilcher R, Hoke T, Adamchak SE, Cates Jr W. Integration of family planning into HIV services: a synthesis of recent evidence. AIDS. 2013;27 Suppl 1:S65–75.CrossRefPubMed
23.
Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006;296(7):782–93.CrossRefPubMed
24.
World Health Organization Department of Reproductive Health and research (WHO/RHR), Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP) Knowledge for Health Project. Family planning: A global handbook for providers (2011 update). Baltimore and Geneva: CCP and WHO; 2011.
25.
Chibwesha CJ, Li MS, Matoba CK, Mbewe RK, Chi BH, Stringer JS, Stringer EM. Modern contraceptive and dual method use among HIV-infected women in Lusaka, Zambia. Infect Dis Obstet Gynecol. 2011;2011:261453.CrossRefPubMedPubMedCentral
26.
Ogbe AE, Mutihir JT. Pattern of contraception among HIV positive women in Jos University Teaching Hospital. Niger J Med. 2012;21(1):11–5.PubMed
27.
Kaida A, Laher F, Strathdee SA, Money D, Janssen PA, Hogg RS, Gray G. Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment services. PLoS One. 2010;5(11):e13868.CrossRefPubMedPubMedCentral
28.
Hoffman IF, Martinson FE, Powers KA, Chilongozi DA, Msiska ED, Kachipapa EI, Mphande CD, Hosseinipour MC, Chanza HC, Stephenson R et al. The year-long effect of HIV-positive test results on pregnancy intentions, contraceptive use, and pregnancy incidence among Malawian women. J Acquir Immune Defic Syndr. 2008;47(4):477–83.CrossRefPubMed
29.
McCoy SI, Buzdugan R, Ralph LJ, Mushavi A, Mahomva A, Hakobyan A, Watadzaushe C, Dirawo J, Cowan FM, Padian NS. Unmet Need for Family Planning, Contraceptive Failure, and Unintended Pregnancy among HIV-Infected and HIV-Uninfected Women in Zimbabwe. PLoS One. 2014;9(8):e105320.CrossRefPubMedPubMedCentral
30.
Antelman G, Medley A, Mbatia R, Pals S, Arthur G, Haberlen S, Ackers M, Elul B, Parent J, Rwebembera A et al. Pregnancy desire and dual method contraceptive use among people living with HIV attending clinical care in Kenya, Namibia and Tanzania. J Fam Plann Reprod Health Care. 2015;41(1):e1.CrossRefPubMedPubMedCentral
31.
Robinson JA, Jamshidi R, Burke AE. Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy. Infect Dis Obstet Gynecol. 2012;2012:890160.CrossRefPubMedPubMedCentral
32.
Barber TJ, Waters L. Implanon failure and antiretroviral therapy. J Fam Plann Reprod Health Care. 2008;34(1):67. author reply 67.CrossRefPubMed
33.
Carten ML, Kiser JJ, Kwara A, Mawhinney S, Cu-Uvin S. Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz. Infect Dis Obstet Gynecol. 2012;2012:137192.CrossRefPubMedPubMedCentral
34.
El-Ibiary SY, Cocohoba JM. Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives. Eur J Contracept Reprod Health Care. 2008;13(2):123–32.CrossRefPubMed
35.
36.
Landolt NK, Phanuphak N, Ubolyam S, Pinyakorn S, Kriengsinyot R, Ahluwalia J, Thongpaeng P, Gorowara M, Thammajaruk N, Chaithongwongwatthana S et al. Efavirenz, in contrast to nevirapine, is associated with unfavorable progesterone and antiretroviral levels when coadministered with combined oral contraceptives. J Acquir Immune Defic Syndr. 2013;62(5):534–9.CrossRefPubMed
37.
Leticee N, Viard JP, Yamgnane A, Karmochkine M, Benachi A. Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz. Contraception. 2012;85(4):425–7.CrossRefPubMed
38.
Matiluko AA, Soundararjan L, Hogston P. Early contraceptive failure of Implanon in an HIV-seropositive patient on triple antiretroviral therapy with zidovudine, lamivudine and efavirenz. J Fam Plann Reprod Health Care. 2007;33(4):277–8.CrossRefPubMed
39.
McCarty EJ, Keane H, Quinn K, Quah S. Implanon(R) failure in an HIV-positive woman on antiretroviral therapy resulting in two ectopic pregnancies. Int J STD AIDS. 2011;22(7):413–4.CrossRefPubMed
40.
Scarsi K, Lamorde M, Darin K, Penchala SD, Else L, Nakalema S, Byakika-Kibwika P, Khoo S, Cohn S, Merry C et al. Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant. J Int AIDS Soc. 2014;17(4 Suppl 3):19484.PubMedPubMedCentral
41.
Perry SH, Swamy P, Preidis GA, Mwanyumba A, Motsa N, Sarero HN. Implementing the Jadelle implant for women living with HIV in a resource-limited setting in sub-Saharan Africa: concerns for drug interactions leading to unintended pregnancies. AIDS 2014
42.
Power J, French R, Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev. 2007;3:CD001326.PubMed
43.
Sivin I, Campodonico I, Kiriwat O, Holma P, Diaz S, Wan L, Biswas A, Viegas O, el din Abdalla K, Anant MP et al. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study. Hum Reprod. 1998;13(12):3371–8.CrossRefPubMed
44.
Wan LS, Stiber A, Lam LY. The levonorgestrel two-rod implant for long-acting contraception: 10 years of clinical experience. Obstet Gynecol. 2003;102(1):24–6.PubMed
45.
Grossman D, Onono M, Newmann SJ, Blat C, Bukusi EA, Shade SB, Steinfeld RL, Cohen CR. Integration of family planning services into HIV care and treatment in Kenya: a cluster-randomized trial. AIDS. 2013;27 Suppl 1:S77–85.CrossRefPubMed
46.
Schwartz SR, Rees H, Mehta S, Venter WD, Taha TE, Black V. High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One. 2012;7(4):e36039.CrossRefPubMedPubMedCentral
47.
King R, Khana K, Nakayiwa S, Katuntu D, Homsy J, Lindkvist P, Johansson E, Bunnell R. ‘Pregnancy comes accidentally--like it did with me’: reproductive decisions among women on ART and their partners in rural Uganda. BMC Public Health. 2011;11:530.CrossRefPubMedPubMedCentral
48.
Neukom J, Chilambwe J, Mkandawire J, Mbewe RK, Hubacher D. Dedicated providers of long-acting reversible contraception: new approach in Zambia. Contraception. 2011;83(5):447–52.CrossRefPubMed
49.
Asfaw HM, Gashe FE. Fertility intentions among HIV positive women aged 18–49 years in Addis Ababa Ethiopia: a cross sectional study. Reprod Health. 2014;11:36.CrossRefPubMedPubMedCentral
50.
Mantell JE, Exner TM, Cooper D, Bai D, Leu CS, Hoffman S, Myer L, Moodley J, Kelvin EA, Constant D et al. Pregnancy intent among a sample of recently diagnosed HIV-positive women and men practicing unprotected sex in Cape Town, South Africa. J Acquir Immune Defic Syndr. 2014;67 Suppl 4:S202–9.CrossRefPubMedPubMedCentral
51.
Lopez LM, Otterness C, Chen M, Steiner M, Gallo MF. Behavioral interventions for improving condom use for dual protection. Cochrane Database Syst Rev. 2013;10:CD010662.PubMed
Metadata
Title
Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional survey
Authors
Nancy L. Hancock
Carla J. Chibwesha
Samuel Bosomprah
Jonathan Newman
Mwangelwa Mubiana-Mbewe
Elizabeth Siyama Sitali
Carolyn Bolton-Moore
Clara Mbwili-Muleya
Benjamin H. Chi
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2016
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-016-3070-5

Other articles of this Issue 1/2016

BMC Public Health 1/2016 Go to the issue

Research article

How do children travel to school in urban India? A cross-sectional study of 5,842 children in Hyderabad

Research article

Factors influencing mother’s participation in Posyandu for improving nutritional status of children under-five in Aceh Utara district, Aceh province, Indonesia

Research article

Reducing routine vaccination dropout rates: evaluating two interventions in three Kenyan districts, 2014

Research article

Musculoskeletal pain and re-employment among unemployed job seekers: a three-year follow-up study

Research article

The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort

Research article

Pessimism and risk of death from coronary heart disease among middle-aged and older Finns: an eleven-year follow-up study